ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,473.17
      -0.25%
      US Tech 100
      19,283.60
      -0.64%
      Dow Jones
      39,134.76
      0.77%
      Brent Oil
      84.935
      -0.08%
      Bitcoin
      64,910.19
      0.14%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. PureTech Health PLC (PRTC)

      7. PureTech Health PLC (PRTC) News

      PRTC

      PureTech Health (PRTC)

      PureTech Health PLC
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:PRTC
      DateTimeSourceHeadlineSymbolCompany
      06/20/20242:00AMBusiness WirePureTech Announces Change of Board RoleNASDAQ:PRTCPureTech Health PLC
      06/18/20247:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamNASDAQ:PRTCPureTech Health PLC
      06/13/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
      06/13/20241:15PMBusiness WirePureTech Health: Results of Annual General MeetingNASDAQ:PRTCPureTech Health PLC
      06/06/20244:39PMEdgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
      06/06/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
      06/06/202412:38PMBusiness WirePureTech Health: Result of General MeetingNASDAQ:PRTCPureTech Health PLC
      06/04/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
      06/04/20247:01AMEdgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:PRTCPureTech Health PLC
      05/30/20248:05AMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRTCPureTech Health PLC
      05/29/20244:33PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
      05/29/20248:09AMBusiness WirePureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyNASDAQ:PRTCPureTech Health PLC
      05/23/20247:00AMBusiness WirePureTech to Present at the Jefferies Global Healthcare ConferenceNASDAQ:PRTCPureTech Health PLC
      05/21/20247:05AMBusiness WirePureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionNASDAQ:PRTCPureTech Health PLC
      05/20/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
      05/20/20247:03AMEdgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:PRTCPureTech Health PLC
      05/20/20242:00AMBusiness WirePureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareNASDAQ:PRTCPureTech Health PLC
      05/09/20247:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual MeetingNASDAQ:PRTCPureTech Health PLC
      05/07/20247:05AMBusiness WirePureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive AppointmentsNASDAQ:PRTCPureTech Health PLC
      04/25/20245:22AMBusiness WirePureTech Announces Annual Results for Year Ended December 31, 2023NASDAQ:PRTCPureTech Health PLC
      04/18/20242:00AMBusiness WirePureTech Health: Notice of ResultsNASDAQ:PRTCPureTech Health PLC
      04/16/20247:00AMBusiness WirePureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary FibrosisNASDAQ:PRTCPureTech Health PLC
      04/11/20247:00AMBusiness WirePureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck CancersNASDAQ:PRTCPureTech Health PLC
      04/09/20242:00AMBusiness WirePureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management TransitionsNASDAQ:PRTCPureTech Health PLC
      03/19/20243:00AMBusiness WirePureTech Proposes $100 Million Capital ReturnNASDAQ:PRTCPureTech Health PLC
      03/18/20249:52AMBusiness WireBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 BillionNASDAQ:PRTCPureTech Health PLC
      03/13/20247:00AMBusiness WirePureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid LeukemiaNASDAQ:PRTCPureTech Health PLC
      02/27/20247:00AMBusiness WirePureTech to Present at Two Upcoming Investor ConferencesNASDAQ:PRTCPureTech Health PLC
      02/27/20242:00AMBusiness WirePureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in JapanNASDAQ:PRTCPureTech Health PLC
      01/04/20244:30PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTCPureTech Health PLC
       Showing the most relevant articles for your search:NASDAQ:PRTC